23.83k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Watchlist | Change today | 1-month return | 1-year return | Total return |
---|---|---|---|---|
The fight against COVID19 | +1.50% | - | - | - |
^GSPC | +1.11% | -0.43% | +20.31% | +5770.00% |
Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
---|---|---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | 160.64 | +1.00 | +0.63% | 4:00 pm GMT-4 | 5.84M | 7.31M | 386.61B |
ABBV | AbbVie Inc. | 185.16 | +2.99 | +1.64% | 4:00 pm GMT-4 | 6.95M | 5.46M | 326.97B |
PFE | Pfizer Inc. | 30.77 | +1.01 | +3.39% | 4:01 pm GMT-4 | 30.49M | 36.71M | 174.36B |
SNY | Sanofi | 52.4 | -0.70 | -1.32% | 4:00 pm GMT-4 | 1.97M | 2.36M | 131.34B |
REGN | Regeneron Pharmaceuticals, Inc. | 1078.63 | +14.44 | +1.36% | 4:00 pm GMT-4 | 375.29k | 437.65k | 118.85B |
GILD | Gilead Sciences, Inc. | 77.01 | +0.50 | +0.65% | 4:00 pm GMT-4 | 7.45M | 7.45M | 95.94B |
GSK | GSK plc | 39.86 | +0.79 | +2.02% | 4:00 pm GMT-4 | 2.82M | 3.61M | 81.28B |
MRNA | Moderna, Inc. | 122.11 | +1.71 | +1.42% | 4:00 pm GMT-4 | 1.88M | 3.94M | 46.80B |
TAK | Takeda Pharmaceutical Company Limited | 13.77 | +0.10 | +0.73% | 4:00 pm GMT-4 | 2.45M | 1.68M | 43.97B |
BNTX | BioNTech SE | 85.94 | +1.26 | +1.49% | 4:00 pm GMT-4 | 265.19k | 726.62k | 20.71B |
NVAX | Novavax, Inc. | 17.11 | +0.44 | +2.64% | 4:00 pm GMT-4 | 7.13M | 17.12M | 2.52B |
VIR | Vir Biotechnology, Inc. | 10.7 | +0.04 | +0.38% | 4:00 pm GMT-4 | 586.94k | 1.16M | 1.46B |
INO | Inovio Pharmaceuticals, Inc. | 11.32 | +0.37 | +3.38% | 4:00 pm GMT-4 | 573.27k | 382.97k | 293.31M |
Big Tech earnings are on deck next week as Microsoft (MSFT), Meta Platforms (META), Apple (AAPL), and Amazon (AMZN) are scheduled to report their second quarter results. Jobs data for July are due out on Friday, August 2, making for a busy week for the US economy as Federal Reserve officials meet for their July FOMC meeting. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Luke Carberry Mogan.
These stocks arguably deserve more respect from investors.
The National Advisory Committee on Immunization's (NACI) annual Statement on Seasonal Influenza Vaccines for 2024-2025 continues to recommend Fluzone® High-Dose Quadrivalent among the preferential influenza vaccines, over standard dose influenza vaccines, to protect adults 65 years of age and older against influenza. According to NACI, Fluzone® High-Dose Quadrivalent has the most substantial body of supporting evidence among preferentially recommended vaccines for adults 65 years of age and olde